| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | 
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Total Revenue | 53.91M | 70.08M | 43.36M | 76.70M | 59.48M | 110.67M | 
| Gross Profit | 25.02M | 63.44M | 27.85M | 60.93M | 41.71M | 86.20M | 
| EBITDA | 10.40M | 32.08M | -152.76M | 20.05M | 21.09M | 77.57M | 
| Net Income | 11.46M | 22.50M | -161.79M | 5.37M | 1.14M | 48.71M | 
| Balance Sheet | ||||||
| Total Assets | 938.46M | 757.15M | 492.53M | 655.34M | 679.10M | 514.93M | 
| Cash, Cash Equivalents and Short-Term Investments | 114.03M | 246.72M | 81.14M | 102.91M | 113.35M | 93.20M | 
| Total Debt | 4.64M | 443.00K | 3.52M | 697.00K | 3.98M | 390.00K | 
| Total Liabilities | 430.71M | 255.80M | 182.59M | 183.61M | 212.73M | 49.71M | 
| Stockholders Equity | 507.76M | 501.36M | 309.94M | 471.73M | 466.36M | 465.23M | 
| Cash Flow | ||||||
| Free Cash Flow | 48.87M | 41.30M | 25.87M | -6.22M | 34.65M | 46.03M | 
| Operating Cash Flow | 48.88M | 41.32M | 25.97M | -6.05M | 34.75M | 46.05M | 
| Investing Cash Flow | -19.27M | -32.92M | -43.31M | 2.94M | -4.32M | -23.00K | 
| Financing Cash Flow | -13.18M | 166.83M | -3.58M | -4.06M | -3.31M | -1.57M | 
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth | 
|---|---|---|---|---|---|---|---|
| ― | HK$208.00M | 71.72 | 0.81% | ― | -21.78% | -19.44% | |
| ― | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
| ― | HK$413.58M | 25.74 | 2.26% | 2.14% | -14.94% | ― | |
| ― | HK$614.27M | ― | -16.07% | ― | 110.52% | 2.14% | |
| ― | €246.86M | 17.99 | 1.47% | ― | 22.62% | ― | |
| ― | ― | ― | ― | ― | -73.92% | 75.00% | 
Da Yu Financial Holdings Limited announced the results of its one-for-two rights issue, which was oversubscribed by approximately 11.38%. The rights issue received 11 valid acceptances and applications, totaling 1,269,041,421 Rights Shares, exceeding the maximum offering of 1,139,330,190 Rights Shares. The excess applications were allocated on a pro-rata basis, and the scale-down mechanism was not triggered, ensuring the company’s public float remains above 25%.
Da Yu Financial Holdings Limited reported its interim results for the six months ending June 30, 2025, showing a decrease in total revenue from HK$24,832,000 in 2024 to HK$23,289,000 in 2025. Despite the decline in revenue, the company achieved a total comprehensive income of HK$16,427,000, aided by exchange differences on foreign subsidiaries. The results indicate a challenging period with reduced profitability, impacting the company’s earnings per share, which decreased from 1.24 HK cents to 0.65 HK cents. This reflects a need for strategic adjustments to improve financial performance and shareholder value.
Da Yu Financial Holdings Limited has announced a board meeting scheduled for August 26, 2025, to approve the interim results for the first half of the year and consider declaring an interim dividend. This meeting is significant as it will provide insights into the company’s financial performance and potential shareholder returns, impacting its market positioning and stakeholder interests.
Da Yu Financial Holdings Limited has announced a significant reduction in its net profit after tax for the first half of 2025, reporting approximately HK$15.0 million compared to HK$26.0 million in the same period of 2024. This decline is mainly due to reduced investment gains from fixed income investments. The interim results are yet to be finalized, and the figures are based on unaudited management accounts, subject to adjustments. Stakeholders are advised to exercise caution when dealing with the company’s shares.
Da Yu Financial Holdings Limited has announced a proposed rights issue to raise approximately HK$136.7 million. The company plans to issue up to 1,139,330,190 rights shares at a subscription price of HK$0.12 per share, on a one-for-two basis to qualifying shareholders. The net proceeds, estimated at HK$136.1 million, will be used primarily for the company’s margin financing business and general working capital. The rights issue will proceed on a non-underwritten basis and does not require shareholder approval, as it complies with the relevant listing rules. Shareholders are advised to exercise caution as the rights issue is subject to certain conditions, and their shareholdings may be diluted if they do not fully take up their entitlements.